SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

09 Nov 2021 Evaluate
The company witnessed a 19.83% growth in the revenue at Rs. 1103.82 millions for the quarter ended September 2021 as compared to Rs. 921.12 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 198.47  millions from Rs. 235.47 millions ,decline by -15.71%.The Operating Profit of the company witnessed a decrease to 272.29 millions from 323.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1103.82 921.12 19.83 1885.94 1387.31 35.94 3328.44 2614.77 27.29
Other Income 42.85 40.49 5.83 70.24 60.95 15.24 113.20 83.21 36.04
PBIDT 272.29 323.20 -15.75 445.20 419.75 6.06 860.73 390.34 120.51
Interest 0.69 0.45 53.33 1.54 0.90 71.11 5.00 2.21 126.24
PBDT 271.60 322.75 -15.85 443.66 418.85 5.92 855.73 388.13 120.48
Depreciation 8.05 8.88 -9.35 17.25 18.36 -6.05 36.70 43.59 -15.81
PBT 263.55 313.87 -16.03 426.41 400.49 6.47 819.03 344.54 137.72
TAX 65.08 78.40 -16.99 107.37 100.74 6.58 207.14 93.71 121.04
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 198.47 235.47 -15.71 319.04 299.75 6.44 611.89 250.83 143.95
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 24.67 35.09 -29.70 23.61 30.26 -21.98 25.86 14.93 73.23

Amrutanjan Healthcar Share Price

543.15 -3.35 (-0.61%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×